Obezite Cerrahisine Hazırlık – Obez Hastalarda Görülen Kardiyolojik Problemler, Preoperatif ve Postoperatif Takip Prensipleri

Jensen M, et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. J Am Coll Cardiol. 2014 Jul, 63 (25_Part_B) 2985–3023.

Harada T, Obokata M. Obesity-Related Heart Failure with Preserved Ejection Fraction: Pathophysiology, Diagnosis, and Potential Therapies. Heart Fail Clin. 2020 Jul;16(3):357-368.

Ayinapudi K, et al. Obesity and Pulmonary Hypertension. Curr Hypertens Rep. 2018 Oct 5;20(12):99.

Lavie CJ, et al. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise. J Am Coll Cardiol. 2017 Oct 17;70(16):2022-2035.

Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6.

Bryan Williams, et al. ESC Scientific Document Group, 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), European Heart Journal, Volume 39, Issue 33, 01 September 2018, Pages 3021–310.

Aydoğdu, Sinan, et al. "Türk hipertansiyon uzlaşı raporu 2019." Turk Kardiyol Dern Ars 47.6 (2019): 535-546.

Jordan J, Kurschat C, Reuter H. Arterial Hypertension. Dtsch Arztebl Int. 2018 Aug 20;115(33-34):557-568.

Van den Berg MP et al. Heart failure and atrial fibrillation: current concepts and controversies. Heart. 1997 Apr;77(4):309-13.

Verhaert DVM, et al. The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases. Europace. 2021 Apr 10;23(23 Suppl 2):ii40-ii45

Bhupathiraju SN, Hu FB. Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications. Circ Res. 2016 May 27;118(11):1723-35.

Mohammadi H, et al. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. Eur J Prev Cardiol. 2020 Dec;27(18):1944-1952.

Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002 Dec;10 Suppl 2:97S-104S. doi: 10.1038/oby.2002.202. PMID: 12490658.

Kayikçioǧlu, M, et al. "Türkiye'de Dislipidemi Sıklığı ve Lipit Verileri: Kardiyovasküler Risk Faktörlerine Yönelik Epidemiyolojik Çalişmaların Sistematik Derleme ve Meta-Analizi." (2018).

Tokgozoglu L, Kayikcioglu M. Familial Hypercholesterolemia: Global Burden and Approaches. Curr Cardiol Rep. 2021 Sep 4;23(10):151.

Theresa A McDonagh, et al. ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3599–3726.

Hage C, et al. Metabolomic Profile in HFpEF vs HFrEF Patients. J Card Fail. 2020 Dec;26(12):1050-1059.

van Heerebeek L, et al. Molecular and cellular basis for diastolic dysfunction. Curr Heart Fail Rep. 2012 Dec;9(4):293-302.

Marc Humbert, et al. ESC/ERS Scientific Document Group, 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal, Volume 43, Issue 38, 7 October 2022, Pages 3618–3731.

Ayinapudi K, et al. Obesity and Pulmonary Hypertension. Curr Hypertens Rep. 2018 Oct 5;20(12):99.

Yuan S, et al. Overall and abdominal obesity in relation to venous thromboembolism. J Thromb Haemost. 2021 Feb;19(2):460-469.

Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):3-14.

Sigrun Halvorsen, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC), European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3826–3924.

Steffel J, et al. 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021;23:1612–1676.

Visseren FLJ, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227–3337.

Devereaux PJ, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014;370:1494–1503.

Graham MM, et al. Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Ann Intern Med 2018;168:237–244.